Yzaguirre Amanda D, Howell Elizabeth D, Li Yan, Liu Zijing, Speck Nancy A
Abramson Family Cancer Research Institute, Department of Cell and Developmental Biology, Institute for Regenerative Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
Beijing Institute of Biotechnology, Beijing 100850, People's Republic of China.
Development. 2018 Jan 29;145(2):dev158162. doi: 10.1242/dev.158162.
Hematopoietic cells differentiate during embryogenesis from a population of endothelial cells called hemogenic endothelium (HE) in a process called the endothelial-to-hematopoietic transition (EHT). The transcription factor Runx1 is required for EHT, but for how long and which endothelial cells are competent to respond to Runx1 are not known. Here, we show that the ability of Runx1 to induce EHT in non-hemogenic endothelial cells depends on the anatomical location of the cell and the developmental age of the conceptus. Ectopic expression of Runx1 in non-hemogenic endothelial cells between embryonic day (E) 7.5 and E8.5 promoted the formation of erythro-myeloid progenitors (EMPs) specifically in the yolk sac, the dorsal aorta and the heart. The increase in EMPs was accompanied by a higher frequency of HE cells able to differentiate into EMPs Expression of Runx1 just 1 day later (E8.5-E9.5) failed to induce the ectopic formation of EMPs. Therefore, endothelial cells, located in specific sites in the conceptus, have a short developmental window of competency during which they can respond to Runx1 and differentiate into blood cells.
造血细胞在胚胎发生过程中,通过一种称为内皮向造血转变(EHT)的过程,从一群称为造血内皮(HE)的内皮细胞分化而来。转录因子Runx1是EHT所必需的,但Runx1需要作用多长时间以及哪些内皮细胞能够对Runx1作出反应尚不清楚。在这里,我们表明Runx1在非造血内皮细胞中诱导EHT的能力取决于细胞的解剖位置和胚胎的发育年龄。在胚胎第(E)7.5天至E8.5天之间,Runx1在非造血内皮细胞中的异位表达促进了红系髓系祖细胞(EMP)的形成,特别是在卵黄囊、背主动脉和心脏中。EMP的增加伴随着能够分化为EMP的HE细胞频率的提高。仅在1天后(E8.5 - E9.5)表达Runx1未能诱导EMP的异位形成。因此,位于胚胎特定部位的内皮细胞具有短暂的发育感受态窗口,在此期间它们能够对Runx1作出反应并分化为血细胞。
Development. 2016-12-1
J Biol Chem. 2015-5-22
Adv Exp Med Biol. 2017
Am J Physiol Heart Circ Physiol. 2024-8-1
Adv Exp Med Biol. 2023
Curr Top Dev Biol. 2016